Fei Zhou

1.2k total citations
54 papers, 977 citations indexed

About

Fei Zhou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Fei Zhou has authored 54 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 21 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Fei Zhou's work include NF-κB Signaling Pathways (10 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Fei Zhou is often cited by papers focused on NF-κB Signaling Pathways (10 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (6 papers). Fei Zhou collaborates with scholars based in China, United States and Switzerland. Fei Zhou's co-authors include Jinke Wang, Xinhui Xu, Lei Zhang, Jun Yang, Jiawang Ding, Hui Wu, En‐Min Li, Yang‐Min Xie, Jian‐Jun Xie and Li‐Yan Xu and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Analytical Chemistry.

In The Last Decade

Fei Zhou

47 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Zhou China 19 562 274 158 134 94 54 977
Qian Xu China 21 707 1.3× 433 1.6× 162 1.0× 109 0.8× 57 0.6× 82 1.3k
Huihui Ma China 22 493 0.9× 223 0.8× 229 1.4× 258 1.9× 68 0.7× 66 1.2k
Wen Zheng China 17 912 1.6× 170 0.6× 171 1.1× 143 1.1× 80 0.9× 40 1.3k
Antonios N. Gargalionis Greece 22 614 1.1× 230 0.8× 190 1.2× 126 0.9× 137 1.5× 60 1.2k
Dongmei Zhang China 19 528 0.9× 113 0.4× 157 1.0× 161 1.2× 81 0.9× 78 1.1k
Hongyan Liang China 20 749 1.3× 324 1.2× 205 1.3× 140 1.0× 89 0.9× 49 1.3k
Lingling Liu China 22 645 1.1× 238 0.9× 267 1.7× 119 0.9× 122 1.3× 83 1.3k
Liliane Massaad-Massade France 21 621 1.1× 194 0.7× 138 0.9× 112 0.8× 48 0.5× 49 1.1k

Countries citing papers authored by Fei Zhou

Since Specialization
Citations

This map shows the geographic impact of Fei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Zhou more than expected).

Fields of papers citing papers by Fei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Zhou. The network helps show where Fei Zhou may publish in the future.

Co-authorship network of co-authors of Fei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Zhou. A scholar is included among the top collaborators of Fei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Zhou. Fei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Zhiyi, Yufeng Zheng, Caoyang Yu, et al.. (2025). Novel drug research and therapeutic strategies targeting tumor metastasis and cancer stem cells. Frontiers in Pharmacology. 16. 1643183–1643183.
3.
Zhou, Fei, et al.. (2025). SDC4 identified as an oncogenic target gene of NF-κB in TNFα-Induced tumor cells. Scientific Reports. 15(1). 16103–16103.
4.
Zhou, Fei, Zhihao Xu, Pengfei Hou, et al.. (2024). Functionalized DNA Origami‐Enabled Detection of Biomarkers. ChemBioChem. 25(13). e202400227–e202400227. 7 indexed citations
5.
Liu, Dacheng, et al.. (2024). Bone marrow mesenchymal stem cell-derived exosomes promote osteoblast proliferation, migration and inhibit apoptosis by regulating KLF3-AS1/miR-338-3p. BMC Musculoskeletal Disorders. 25(1). 122–122. 3 indexed citations
6.
Ma, Xiaowei, Fei Zhou, Donglei Yang, et al.. (2023). miRNA Detection for Prostate Cancer Diagnosis by miRoll-Cas: miRNA Rolling Circle Transcription for CRISPR-Cas Assay. Analytical Chemistry. 95(35). 13220–13226. 26 indexed citations
7.
Zhang, Qianqian, Yuanming Li, Dan Liu, et al.. (2023). Homer1 ameliorates ischemic stroke by inhibiting necroptosis-induced neuronal damage and neuroinflammation. Inflammation Research. 73(1). 131–144. 5 indexed citations
8.
Du, Zhibo, Peng Wang, Peng Luo, et al.. (2023). Mechanical mechanism and indicator of diffuse axonal injury under blast-type acceleration. Journal of Biomechanics. 156. 111674–111674. 3 indexed citations
9.
Zhao, Lu, et al.. (2021). Food sources and trophic levels of terrestrial cave fauna in Yuping Town, Libo County, Guizhou Province. Biodiversity Science. 29(8). 1108–1119.
10.
Deng, Jin, Lijun Zhang, Jingling Zhao, et al.. (2020). Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma. BMC Cancer. 20(1). 927–927. 17 indexed citations
11.
Yang, Wei, Jun Yang, Jiawang Ding, et al.. (2017). Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. DNA and Cell Biology. 36(6). 475–481. 88 indexed citations
12.
Yao, Zhiqiang, Juntang Li, Zhongyu Liu, et al.. (2016). Integrative bioinformatics and proteomics-based discovery of an eEF2K inhibitor (cefatrizine) with ER stress modulation in breast cancer cells. Molecular BioSystems. 12(3). 729–736. 17 indexed citations
13.
Du, Zepeng, Bingli Wu, Yang‐Min Xie, et al.. (2015). Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(10). 2240–2250. 28 indexed citations
14.
Zhou, Fei, et al.. (2013). Analyzing transcription factor activity using near infrared fluorescent bridge polymerase chain reaction. Analytical Biochemistry. 448. 105–112. 8 indexed citations
15.
Ji, Xituan, Niansong Qian, Tao Zhang, et al.. (2013). Spinal Astrocytic Activation Contributes to Mechanical Allodynia in a Rat Chemotherapy-Induced Neuropathic Pain Model. PLoS ONE. 8(4). e60733–e60733. 96 indexed citations
16.
Xue, Peng, Fei Zhou, Ning Li, Min Li, & Liwei Wang. (2012). Clinical significance of the expressions of PTEN and p-AKT proteins in gastric carcinoma and its relationship to prognosis. Tumori. 32(4). 281–285. 1 indexed citations
17.
Zhang, Wei, Koji Murao, Xiang Zhang, et al.. (2010). Resveratrol represses YKL-40 expression in human glioma U87 cells. BMC Cancer. 10(1). 593–593. 34 indexed citations
18.
Xie, Jian‐Jun, Li‐Yan Xu, Yang‐Min Xie, et al.. (2008). Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. International Journal of Cancer. 124(11). 2549–2558. 69 indexed citations
19.
Xiang, Ruo‐Lan, Fei Zhou, Ying Yang, & Jing‐Pian Peng. (2003). Construction of the Plasmid pCMV4-rZPC′ DNA Vaccine and Analysis of Its Contraceptive Potential1. Biology of Reproduction. 68(5). 1518–1524. 31 indexed citations
20.
Zhou, Fei, Ying Yang, & Jing‐Pian Peng. (2001). Construction of the plasmid pCMV4-rZPC^ DNA vaccine and analysis of its expression in mouse. Dongwuxue zazhi. 36(3). 22–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026